Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4278 studies found for:    Open Studies | "Immune System Diseases"
Show Display Options
Rank Status Study
21 Recruiting Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction
Conditions: Cirrhosis;   Liver Failure
Interventions: Drug: Human derived Transfer factor;   Drug: Aqua pro injectione 4ml ampules for subcutaneous injection
22 Recruiting Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
23 Recruiting Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Condition: Graft vs Host Disease
Interventions: Biological: Begelomab;   Biological: Conventional Second-line Treatment
24 Recruiting Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: Entospletinib;   Drug: Placebo;   Drug: Systemic Corticosteroids
25 Recruiting Women Empowered to Live With Lupus Study
Condition: Lupus Erythematosus, Systemic
Intervention: Behavioral: Chronic Disease Self-Management Program (CDSMP)
26 Recruiting A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: KD025
27 Recruiting Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus Type 1;   Autoimmune Diseases;   Endocrine System Diseases;   Glucose Metabolism Disorders;   Immune System Diseases;   Metabolic Diseases
Intervention: Biological: Stem Cell Transplantation
28 Recruiting Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
Conditions: Lymphoma;   Lymphoma, Non-Hodgkin;   Immune System Diseases;   Immunoproliferative Disorders;   Lymphatic Diseases;   Lymphoproliferative Disorders;   Neoplasms;   Neoplasms by Histologic Type
Intervention: Biological: ATLCAR.CD30 cells
29 Recruiting Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
Conditions: Hodgkin Disease;   Lymphoma;   Lymphoma, Non-Hodgkin;   Immune System Diseases;   Immunoproliferative Disorders;   Lymphatic Diseases;   Lymphoproliferative Disorders;   Neoplasms;   Neoplasms by Histologic Type
Intervention: Drug: ATLCAR.CD30 cells
30 Recruiting Detection and Characterization of Infections and Infection Susceptibility
Conditions: Immune Disorders;   Chronic Granulomatous Disease;   Genetic Immunological Deficiencies;   Hyperimmunoglobulin-E Recurrent Infection Syndrome;   Recurrent Infections;   Unknown Immune Deficiency;   GATA2 Deficiency (MonoMAC);   Nontuberculous Mycobacterial Infections;   Hyper IgE (Job s) Syndrome;   Leukocyte Adhesion Deficiency;   Susceptibility to Disseminated Infections;   Primary Immune Deficiency Disease (PIDD)
Intervention:
31 Recruiting A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Conditions: Eczema;   Dermatitis;   Dermatitis, Atopic;   Genetic Disease, Inborn;   Hypersensitivity;   Hypersensitivity, Immediate;   Immune System Diseases;   Skin Diseases;   Skin Diseases, Eczematous;   Skin Diseases, Genetic
Interventions: Other: Care provided by general pediatrician;   Other: Care provided by pediatric dermatologist
32 Recruiting Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16
Condition: Humoral Immune Response
Intervention: Biological: Bivigam
33 Not yet recruiting Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease
Condition: Acute Graft Versus Host Disease
Intervention: Biological: MSCTC-0010 Dose Escalation
34 Recruiting Fecal Microbiota Transplantation in Gut aGVHD Treated
Condition: Acute-graft-versus-host Disease
Intervention: Biological: Fecal microbiota
35 Available An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant
Condition: Graft-versus-host Disease (GVHD)
Intervention: Drug: Ruxolitinib
36 Recruiting Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases
Conditions: Autoimmune Diseases;   Advanced Cancer
Intervention: Drug: Checkpoint inhibitor therapy
37 Not yet recruiting GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Condition: Acute Graft-versus-host Disease
Interventions: Drug: Itacitinib;   Drug: Placebo;   Drug: Prednisone;   Drug: Methylprednisolone
38 Recruiting Analysis of Transcriptomic Profile of Graft-versus-host Disease (GHVD) After Allogeneic Grafting of Hematopoietic Stem Cells
Conditions: Graft Vs Host Disease;   Hematopoietic Stem Cells
Intervention: Other: Transcriptomic analysis of GVHD biopsies
39 Not yet recruiting The Association Between Pre-operative Pain Psychology and Hypersensitivity With Poor Functional Outcome After Knee Replacement.
Condition: Outcome After Total Knee Arthroplasty
Intervention: Procedure: total knee arthroplasty
40 Not yet recruiting Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin
Condition: Advanced Malignant Neoplasm
Interventions: Dietary Supplement: Fat Emulsion;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.